Benzinga | Aug 9, 2021 04:09PM EDT

Inovio Pharmaceuticals Q2 EPS $(0.39) Misses $(0.25) Estimate, Sales $272.82K Miss $1.21M Estimate

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.25) by 56 percent. This is a 95 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $272.82 thousand which missed the analyst consensus estimate of $1.21 million by 77.45 percent. This is a 2.11 percent increase over sales of $267.19 thousand the same period last year.